CRH MEDICAL CORP's ticker is CRHM and the CUSIP is 12626F105. A total of 47 filers reported holding CRH MEDICAL CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,872,000 | +6140.0% | 474,000 | +3146.6% | 0.01% | – |
| Q2 2020 | $30,000 | +25.0% | 14,600 | -18.4% | 0.00% | – |
| Q1 2020 | $24,000 | -61.3% | 17,900 | 0.0% | 0.00% | – |
| Q4 2019 | $62,000 | -23.5% | 17,900 | -32.2% | 0.00% | – |
| Q3 2019 | $81,000 | -22.1% | 26,400 | -23.0% | 0.00% | – |
| Q2 2019 | $104,000 | -74.6% | 34,300 | -77.7% | 0.00% | -100.0% |
| Q1 2019 | $410,000 | -39.3% | 154,100 | -30.0% | 0.00% | -50.0% |
| Q4 2018 | $675,000 | -13.2% | 220,300 | +12.6% | 0.00% | 0.0% |
| Q3 2018 | $778,000 | -18.3% | 195,600 | +16.9% | 0.00% | -33.3% |
| Q2 2017 | $952,000 | +19.3% | 167,300 | +71.6% | 0.00% | 0.0% |
| Q1 2017 | $798,000 | +35.5% | 97,500 | -11.7% | 0.00% | +50.0% |
| Q4 2016 | $589,000 | +440.4% | 110,400 | +200.0% | 0.00% | +100.0% |
| Q4 2015 | $109,000 | -42.0% | 36,800 | -37.3% | 0.00% | 0.0% |
| Q3 2015 | $188,000 | – | 58,666 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STADIUM CAPITAL MANAGEMENT LLC | 2,182,483 | $6,657,000 | 2.76% |
| Pacific Ridge Capital Partners, LLC | 1,839,473 | $5,610,000 | 1.87% |
| Nantahala Capital Management | 6,534,155 | $20,028,000 | 0.62% |
| Beutel, Goodman & Co Ltd. | 5,127,100 | $15,703,000 | 0.13% |
| PALLADIUM PARTNERS LLC | 207,900 | $634,000 | 0.05% |
| Connor, Clark & Lunn Investment Management Ltd. | 2,201,799 | $6,739,000 | 0.05% |
| Spark Investment Management LLC | 172,000 | $527,000 | 0.04% |
| SEIZERT CAPITAL PARTNERS, LLC | 170,842 | $521,000 | 0.02% |
| Sepio Capital, LP | 97,844 | $298,000 | 0.02% |
| STIFEL FINANCIAL CORP | 2,116,607 | $6,459,000 | 0.02% |